Cargando…
阿帕替尼用于小细胞肺癌多线治疗后的挽救治疗
Small cell lung cancer (SCLC) was highly malignant and lack effective treatment after the failure of radiotherapy and chemotherapy. Antiangiogenic therapy had shown a certain effect in advanced SCLC. Apatinib, a new potent oral small-molecule tyrosine kinase inhibitor targeting the intracellular dom...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058660/ https://www.ncbi.nlm.nih.gov/pubmed/30037379 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.11 |